Low-dose DDAVP in nocturnal enuresis
Related Experiment Videos
D W Key1, D A Bloom, J Sanvordenker
1Department of Surgery, University of Michigan Medical Center, Ann Arbor.
Clinical Pediatrics
|May 1, 1992
Abstract:
A five-year experience with the vasopressin analogue desmopressin acetate (DDAVP) for nocturnal enuresis is described in 59 children. The initial starting dose of 5 micrograms at bedtime is lower than that reported in other series. Eighty-one percent of patients required 10 micrograms or less to achieve improvement or resolution of bedwetting.